During the past decade, St. Marienhospital - Vechta conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 1 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "St. Marienhospital - Vechta" #1 sponsor was "German CLL Study Group" with 6 trials, followed by "German High-Grade Non-Hodgkin's Lymphoma Study Group" with 5 trials sponsored, "Gesellschaft fur Padiatrische Onkologie und Hamatologie - Germany" with 2 trials sponsored, "Ethicon, Inc." with 1 trials sponsored and "IHF GmbH - Institut für Herzinfarktforschung" with 1 trials sponsored. Other sponsors include -2 different institutions and companies that sponsored additional 8 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "St. Marienhospital - Vechta" #1 collaborator was "Abbott Medical Devices" with 1 trials as a collaborator, "International Anesthesia Research Society (IARS)" with 1 trials as a collaborator and "University of Cologne" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "St. Marienhospital - Vechta" are "Chronic Lymphocytic Leukemia" (6 trials), "Lymphoma" (5 trials), "Anemia" (1 trials), "Brain and Central Nervous System Tumors" (1 trials) and "Breast Cancer" (1 trials). Many other conditions were trialed in "St. Marienhospital - Vechta" in a lesser frequency.

Most popular intervention types in "St. Marienhospital - Vechta" are "Drug" (15 trials), "Biological" (9 trials), "Radiation" (7 trials), "Other" (3 trials) and "Device" (2 trials). Other intervention types were less common.

The name of intervention was led by "cyclophosphamide" (7 trials), "doxorubicin hydrochloride" (7 trials), "radiation therapy" (7 trials), "vincristine sulfate" (7 trials) and "prednisone" (6 trials). Other intervention names were less common.

The vast majority of trials in "St. Marienhospital - Vechta" are 16 trials for "All" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "St. Marienhospital - Vechta". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 17 completed trials in St. Marienhospital - Vechta, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in St. Marienhospital - Vechta, 0 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 12 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".